3 results match your criteria: "National Medical Institute of the Internal Affairs and Administration Ministry[Affiliation]"
Pulsatile Left Ventricular Assistance in High-Risk Percutaneous Coronary Interventions: Short-Term Outcomes.
J Clin Med
September 2024
Department of Cardiology, National Medical Institute of the Internal Affairs and Administration Ministry, 02-005 Warsaw, Poland.
To document the real-world experience with the use of pneumatic pulsatile mechanical circulatory support (MCS) with the PulseCath iVAC2L during high-risk percutaneous coronary interventions (HR-PCIs). : The use of MCS in HR-PCIs may reduce the rate of major adverse cardiovascular events (MACEs) at 90 days. The PulseCath iVAC2L is a short-term pulsatile transaortic left ventricular (LV) assist device that has been in use since 2014.
View Article and Find Full Text PDFCorrection: Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial.
Clin Res Cardiol
July 2024
Department of Cardiology, Faculty of Medicine, Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial.
Clin Res Cardiol
July 2024
Department of Cardiology, Faculty of Medicine, Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.
Article Synopsis
- The INCORPORATE trial aimed to determine if an invasive approach (routine coronary angiography and revascularization) is better than conservative treatment for patients with treated critical limb ischemia.
- Conducted as a randomized study, it compared outcomes between patients receiving optimal medical therapy versus those undergoing invasive procedures, measuring myocardial infarction and mortality over one year.
- Results showed similar rates of heart attacks and death in both groups, but the conservative approach had a trend toward higher major adverse cardiac events, suggesting potential benefits of the invasive strategy for some patients.